Vaccine shortages: History, impact, and prospects for the future

被引:57
作者
Hinman, AR [1 ]
Orenstein, WA
Santoli, JM
Rodewald, LE
Cochi, SL
机构
[1] Task Force Child Survival & Dev, Decatur, GA 30030 USA
[2] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA
[3] Ctr Dis Control & Prevent, Natl Immunizat Program, Atlanta, GA 30333 USA
关键词
immunization; health policy; liability; vaccine manufacture;
D O I
10.1146/annurev.publhealth.27.021405.102248
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Vaccine shortages can result from higher-than-expected demand. interruptions in production/supply, or a lack of resources to purchase vaccines. Each of these factors has played a role in vaccine shortages in the United States during the past 20 years. Since 2000, the United States has experienced an unprecedented series of shortages of vaccines recommended for widespread use against 9 diseases, after more than 15 years without vaccine supply problems. In developing countries, the major cause of vaccine shortages is lack of resources to purchase them. Although there are several steps that could reduce the likelihood of future vaccine shortages, many would take several years to implement. Consequently, we will probably continue to see occasional shortages of vaccines in the United States in the next few years.
引用
收藏
页码:235 / 259
页数:25
相关论文
共 64 条
[1]  
[Anonymous], SUPPLYING VACCINES E
[2]  
AUERBACH S, 1976, WASHINGTON POST 0914, pA1
[3]  
AUERBACH S, 1976, WASHINGTON POST 0914, pA8
[4]  
BART KJ, 1991, JAMA-J AM MED ASSOC, V266, P1547
[5]  
*CENT DIS CONTR PR, 2005, MMWR-MORBID MORTAL W, V54, P304
[6]  
*CENT DIS CONTR PR, 2002, MMWR-MORBID MORTAL W, V52, P987
[7]  
*CENT DIS CONTR PR, 2004, MMWR-MORBID MORTAL W, V53, pQ1
[8]  
*CENT DIS CONTR PR, 2005, CDC VACC PRIC LIST
[9]  
*CENT DIS CONTR PR, 2004, MMWR-MORBID MORTAL W, V53, P1041
[10]  
*CENT DIS CONTR PR, 2004, MMWR-MORBID MORTAL W, V53, P658